NewGenIvf Group Ltd (NASDAQ:NIVF)’s traded shares stood at 0.75 million during the last session, with the company’s beta value hitting -0.04. At the close of trading, the stock’s price was $0.93, to imply a decrease of -6.52% or -$0.06 in intraday trading. The NIVF share’s 52-week high remains $656.00, putting it -70437.63% down since that peak but still an impressive 8.6% since price per share fell to its 52-week low of $0.85. The company has a valuation of $4.00M, with an average of 5.3 million shares in intraday trading volume over the past 10 days and average of 3.96 million shares over the past 3 months.

NewGenIvf Group Ltd (NASDAQ:NIVF) trade information

After registering a -6.52% downside in the last session, NewGenIvf Group Ltd (NIVF) has traded red over the past five days. The 5-day price performance for the stock is -18.10%, and -74.99% over 30 days. With these gigs, the year-to-date price performance is -99.52%. Short interest in NewGenIvf Group Ltd (NASDAQ:NIVF) saw shorts transact 0.37 million shares and set a 0.05 days time to cover.

NIVF Dividends

NewGenIvf Group Ltd has its next earnings report out in August. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

NewGenIvf Group Ltd (NASDAQ:NIVF)’s Major holders

NewGenIvf Group Ltd insiders hold 2.24% of total outstanding shares, with institutional holders owning 0.55% of the shares at 0.56% float percentage. In total, 0.55% institutions holds shares in the company.

Going by data provided on Jan 31, 2025 , Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund holds roughly 48.0 shares. This is just over 0.00% of the total shares, with a market valuation of $44.0